FDA NDC Directory · JSON-LD · Markdown

Bivalirudin

NDC 83634-400 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebivalirudin
Labeler / ManufacturerAvenacy, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210031
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/1)
Marketing started20231218
Package count1

External sources

Source: openFDA. Public-domain (CC0).